Skip to main content
Top
Published in: BMC Gastroenterology 1/2010

Open Access 01-12-2010 | Research article

Angiotensin II receptor expression and relation to Helicobacter pylori-infection in the stomach of the Mongolian gerbil

Authors: Peter Hallersund, Herbert F Helander, Anna Casselbrant, Anders Edebo, Lars Fändriks, Anders Elfvin

Published in: BMC Gastroenterology | Issue 1/2010

Login to get access

Abstract

Background

The role of the renin-angiotensin system in gastric physiology and disease has as yet been sparsely explored. The first aim of the study was to investigate the baseline presence and location of angiotensin II receptors (AT1R and AT2R) in the stomach of the Mongolian gerbil. A second aim was to elucidate whether the presence of H. pylori infection is associated with changes in the expression of these receptors.

Methods

H. pylori-negative and H. pylori-infected (strain SS1 or TN2GF4) male Mongolian gerbils were investigated. The stomachs were examined at six or 12 months after inoculation by the use of immunohistochemistry, western blot and microscopic morphometry.

Results

AT1R and AT2R were located in a variety of cells in the gerbil gastric wall, including a subpopulation of endocrine cells in the antral mucosa and inflammatory cells infiltrating H. pylori-infected stomachs. Gerbils infected with the SS1 strain showed a significantly increased antral AT1R protein expression and an increased number of infiltrating polymorphonuclear leucocytes (PMNs) at 12 months. The AT1R protein expression correlated with the number of PMNs and the antral expression of myeloperoxidase.

Conclusions

Angiotensin II receptors are present in a variety of cells in the gastric wall of the Mongolian gerbil. The results indicate an influence dependent on the H. pylori strain on the gastric AT1R expression and a relationship between gastric AT1R expression and mucosal PMNs infiltration.
Appendix
Available only for authorised users
Literature
1.
go back to reference Chow L, Zakrzewska K, De Gasparo M, Cumin F, Levens N: Gastric acid secretion after blockade of angiotensin AT1 receptors in the Na(+)-depleted rat. Eur J Pharmacol. 1995, 294 (1): 309-317. 10.1016/0014-2999(95)00546-3.CrossRefPubMed Chow L, Zakrzewska K, De Gasparo M, Cumin F, Levens N: Gastric acid secretion after blockade of angiotensin AT1 receptors in the Na(+)-depleted rat. Eur J Pharmacol. 1995, 294 (1): 309-317. 10.1016/0014-2999(95)00546-3.CrossRefPubMed
2.
go back to reference Heinemann A, Sattler V, Jocic M, Wienen W, Holzer P: Effect of angiotensin II and telmisartan, an angiotensin1 receptor antagonist, on rat gastric mucosal blood flow. Aliment Pharmacol Ther. 1999, 13 (3): 347-355. 10.1046/j.1365-2036.1999.00496.x.CrossRefPubMed Heinemann A, Sattler V, Jocic M, Wienen W, Holzer P: Effect of angiotensin II and telmisartan, an angiotensin1 receptor antagonist, on rat gastric mucosal blood flow. Aliment Pharmacol Ther. 1999, 13 (3): 347-355. 10.1046/j.1365-2036.1999.00496.x.CrossRefPubMed
3.
go back to reference Ludtke FE, Golenhofen K, Schubert F: Angiotensin II stimulates human gastric smooth muscle in vitro. J Auton Pharmacol. 1989, 9 (2): 139-147. 10.1111/j.1474-8673.1989.tb00205.x.CrossRefPubMed Ludtke FE, Golenhofen K, Schubert F: Angiotensin II stimulates human gastric smooth muscle in vitro. J Auton Pharmacol. 1989, 9 (2): 139-147. 10.1111/j.1474-8673.1989.tb00205.x.CrossRefPubMed
4.
go back to reference Bregonzio C, Armando I, Ando H, Jezova M, Baiardi G, Saavedra JM: Anti-inflammatory effects of angiotensin II AT1 receptor antagonism prevent stress-induced gastric injury. Am J Physiol Gastrointest Liver Physiol. 2003, 285 (2): G414-423.CrossRefPubMed Bregonzio C, Armando I, Ando H, Jezova M, Baiardi G, Saavedra JM: Anti-inflammatory effects of angiotensin II AT1 receptor antagonism prevent stress-induced gastric injury. Am J Physiol Gastrointest Liver Physiol. 2003, 285 (2): G414-423.CrossRefPubMed
5.
go back to reference Nakagiri A, Sunamoto M, Murakami M: Angiotensin AT1 receptor blockers suppress ischemia/reperfusion-induced gastric injury in rats. Inflammopharmacology. 2007, 15 (4): 171-174. 10.1007/s10787-006-1551-3.CrossRefPubMed Nakagiri A, Sunamoto M, Murakami M: Angiotensin AT1 receptor blockers suppress ischemia/reperfusion-induced gastric injury in rats. Inflammopharmacology. 2007, 15 (4): 171-174. 10.1007/s10787-006-1551-3.CrossRefPubMed
6.
go back to reference Casselbrant A, Edebo A, Wennerblom J, Lonroth H, Helander HF, Vieth M, Lundell L, Fandriks L: Actions by angiotensin II on esophageal contractility in humans. Gastroenterology. 2007, 132 (1): 249-260. 10.1053/j.gastro.2006.11.010.CrossRefPubMed Casselbrant A, Edebo A, Wennerblom J, Lonroth H, Helander HF, Vieth M, Lundell L, Fandriks L: Actions by angiotensin II on esophageal contractility in humans. Gastroenterology. 2007, 132 (1): 249-260. 10.1053/j.gastro.2006.11.010.CrossRefPubMed
7.
go back to reference Hirasawa K, Sato Y, Hosoda Y, Yamamoto T, Hanai H: Immunohistochemical localization of angiotensin II receptor and local renin-angiotensin system in human colonic mucosa. J Histochem Cytochem. 2002, 50 (2): 275-282.CrossRefPubMed Hirasawa K, Sato Y, Hosoda Y, Yamamoto T, Hanai H: Immunohistochemical localization of angiotensin II receptor and local renin-angiotensin system in human colonic mucosa. J Histochem Cytochem. 2002, 50 (2): 275-282.CrossRefPubMed
8.
go back to reference Paul M, Poyan Mehr A, Kreutz R: Physiology of local renin-angiotensin systems. Physiol Rev. 2006, 86 (3): 747-803. 10.1152/physrev.00036.2005.CrossRefPubMed Paul M, Poyan Mehr A, Kreutz R: Physiology of local renin-angiotensin systems. Physiol Rev. 2006, 86 (3): 747-803. 10.1152/physrev.00036.2005.CrossRefPubMed
9.
go back to reference Lavoie JL, Sigmund CD: Minireview: overview of the renin-angiotensin system--an endocrine and paracrine system. Endocrinology. 2003, 144 (6): 2179-2183. 10.1210/en.2003-0150.CrossRefPubMed Lavoie JL, Sigmund CD: Minireview: overview of the renin-angiotensin system--an endocrine and paracrine system. Endocrinology. 2003, 144 (6): 2179-2183. 10.1210/en.2003-0150.CrossRefPubMed
10.
go back to reference Deshayes F, Nahmias C: Angiotensin receptors: a new role in cancer?. Trends Endocrinol Metab. 2005, 16 (7): 293-299. 10.1016/j.tem.2005.07.009.CrossRefPubMed Deshayes F, Nahmias C: Angiotensin receptors: a new role in cancer?. Trends Endocrinol Metab. 2005, 16 (7): 293-299. 10.1016/j.tem.2005.07.009.CrossRefPubMed
11.
go back to reference Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Egido J: Inflammation and angiotensin II. Int J Biochem Cell Biol. 2003, 35 (6): 881-900. 10.1016/S1357-2725(02)00271-6.CrossRefPubMed Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Egido J: Inflammation and angiotensin II. Int J Biochem Cell Biol. 2003, 35 (6): 881-900. 10.1016/S1357-2725(02)00271-6.CrossRefPubMed
12.
go back to reference Sugimoto M, Furuta T, Shirai N, Ikuma M, Sugimura H, Hishida A: Influences of chymase and angiotensin I-converting enzyme gene polymorphisms on gastric cancer risks in Japan. Cancer Epidemiol Biomarkers Prev. 2006, 15 (10): 1929-1934. 10.1158/1055-9965.EPI-06-0339.CrossRefPubMed Sugimoto M, Furuta T, Shirai N, Ikuma M, Sugimura H, Hishida A: Influences of chymase and angiotensin I-converting enzyme gene polymorphisms on gastric cancer risks in Japan. Cancer Epidemiol Biomarkers Prev. 2006, 15 (10): 1929-1934. 10.1158/1055-9965.EPI-06-0339.CrossRefPubMed
13.
go back to reference Sugimoto M, Furuta T, Shirai N, Kodaira C, Nishino M, Ikuma M, Sugimura H, Hishida A: Role of angiotensinogen gene polymorphism on Helicobacter pylori infection-related gastric cancer risk in Japanese. Carcinogenesis. 2007, 28 (9): 2036-2040. 10.1093/carcin/bgm074.CrossRefPubMed Sugimoto M, Furuta T, Shirai N, Kodaira C, Nishino M, Ikuma M, Sugimura H, Hishida A: Role of angiotensinogen gene polymorphism on Helicobacter pylori infection-related gastric cancer risk in Japanese. Carcinogenesis. 2007, 28 (9): 2036-2040. 10.1093/carcin/bgm074.CrossRefPubMed
14.
go back to reference Elfvin A, Bolin I, Von Bothmer C, Stolte M, Watanabe H, Fandriks L, Vieth M: Helicobacter pylori induces gastritis and intestinal metaplasia but no gastric adenocarcinoma in Mongolian gerbils. Scand J Gastroenterol. 2005, 40 (11): 1313-1320. 10.1080/00365520510023611.CrossRefPubMed Elfvin A, Bolin I, Von Bothmer C, Stolte M, Watanabe H, Fandriks L, Vieth M: Helicobacter pylori induces gastritis and intestinal metaplasia but no gastric adenocarcinoma in Mongolian gerbils. Scand J Gastroenterol. 2005, 40 (11): 1313-1320. 10.1080/00365520510023611.CrossRefPubMed
15.
go back to reference Chen D, Stenstrom B, Zhao CM, Wadstrom T: Does Helicobacter pylori infection per se cause gastric cancer or duodenal ulcer? Inadequate evidence in Mongolian gerbils and inbred mice. FEMS Immunol Med Microbiol. 2007, 50 (2): 184-189. 10.1111/j.1574-695X.2007.00249.x.CrossRefPubMed Chen D, Stenstrom B, Zhao CM, Wadstrom T: Does Helicobacter pylori infection per se cause gastric cancer or duodenal ulcer? Inadequate evidence in Mongolian gerbils and inbred mice. FEMS Immunol Med Microbiol. 2007, 50 (2): 184-189. 10.1111/j.1574-695X.2007.00249.x.CrossRefPubMed
16.
go back to reference Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M: Helicobacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterology. 1998, 115 (3): 642-648. 10.1016/S0016-5085(98)70143-X.CrossRefPubMed Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M: Helicobacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterology. 1998, 115 (3): 642-648. 10.1016/S0016-5085(98)70143-X.CrossRefPubMed
17.
go back to reference Lee A, O'Rourke J, De Ungria MC, Robertson B, Daskalopoulos G, Dixon MF: A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology. 1997, 112 (4): 1386-1397. 10.1016/S0016-5085(97)70155-0.CrossRefPubMed Lee A, O'Rourke J, De Ungria MC, Robertson B, Daskalopoulos G, Dixon MF: A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology. 1997, 112 (4): 1386-1397. 10.1016/S0016-5085(97)70155-0.CrossRefPubMed
18.
go back to reference Hoe KL, Saavedra JM: Site-directed mutagenesis of the gerbil and human angiotensin II AT(1) receptors identifies amino acid residues attributable to the binding affinity for the nonpeptidic antagonist losartan. Molecular pharmacology. 2002, 61 (6): 1404-1415. 10.1124/mol.61.6.1404.CrossRefPubMed Hoe KL, Saavedra JM: Site-directed mutagenesis of the gerbil and human angiotensin II AT(1) receptors identifies amino acid residues attributable to the binding affinity for the nonpeptidic antagonist losartan. Molecular pharmacology. 2002, 61 (6): 1404-1415. 10.1124/mol.61.6.1404.CrossRefPubMed
19.
go back to reference Hoe KL, Armando I, Baiardi G, Sreenath T, Kulkarni A, Martinez A, Saavedra JM: Molecular cloning, characterization, and distribution of the gerbil angiotensin II AT2 receptor. American journal of physiology. 2003, 285 (6): R1373-1383.PubMed Hoe KL, Armando I, Baiardi G, Sreenath T, Kulkarni A, Martinez A, Saavedra JM: Molecular cloning, characterization, and distribution of the gerbil angiotensin II AT2 receptor. American journal of physiology. 2003, 285 (6): R1373-1383.PubMed
20.
go back to reference Clauser E, Curnow KM, Davies E, Conchon S, Teutsch B, Vianello B, Monnot C, Corvol P: Angiotensin II receptors: protein and gene structures, expression and potential pathological involvements. Eur J Endocrinol. 1996, 134 (4): 403-411. 10.1530/eje.0.1340403.CrossRefPubMed Clauser E, Curnow KM, Davies E, Conchon S, Teutsch B, Vianello B, Monnot C, Corvol P: Angiotensin II receptors: protein and gene structures, expression and potential pathological involvements. Eur J Endocrinol. 1996, 134 (4): 403-411. 10.1530/eje.0.1340403.CrossRefPubMed
21.
go back to reference Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976, 72: 248-254. 10.1016/0003-2697(76)90527-3.CrossRefPubMed Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976, 72: 248-254. 10.1016/0003-2697(76)90527-3.CrossRefPubMed
22.
go back to reference Li H, Andersson EM, Helander HF: Reactions from rat gastric mucosa during one year of Helicobacter pylori infection. Digestive diseases and sciences. 1999, 44 (1): 116-124. 10.1023/A:1026662402734.CrossRefPubMed Li H, Andersson EM, Helander HF: Reactions from rat gastric mucosa during one year of Helicobacter pylori infection. Digestive diseases and sciences. 1999, 44 (1): 116-124. 10.1023/A:1026662402734.CrossRefPubMed
23.
go back to reference Lee CS, Perreault N, Brestelli JE, Kaestner KH: Neurogenin 3 is essential for the proper specification of gastric enteroendocrine cells and the maintenance of gastric epithelial cell identity. Genes & development. 2002, 16 (12): 1488-1497.CrossRef Lee CS, Perreault N, Brestelli JE, Kaestner KH: Neurogenin 3 is essential for the proper specification of gastric enteroendocrine cells and the maintenance of gastric epithelial cell identity. Genes & development. 2002, 16 (12): 1488-1497.CrossRef
24.
go back to reference Malle E, Furtmuller PG, Sattler W, Obinger C: Myeloperoxidase: a target for new drug development?. British journal of pharmacology. 2007, 152 (6): 838-854. 10.1038/sj.bjp.0707358.CrossRefPubMedPubMedCentral Malle E, Furtmuller PG, Sattler W, Obinger C: Myeloperoxidase: a target for new drug development?. British journal of pharmacology. 2007, 152 (6): 838-854. 10.1038/sj.bjp.0707358.CrossRefPubMedPubMedCentral
25.
go back to reference Matsuo T, Ikura Y, Ohsawa M, Ogami M, Kayo S, Yoshimi N, Hai E, Naruko T, Ohishi M, Higuchi K, et al: Mast cell chymase expression in Helicobacter pylori-associated gastritis. Histopathology. 2003, 43 (6): 538-549. 10.1111/j.1365-2559.2003.01731.x.CrossRefPubMed Matsuo T, Ikura Y, Ohsawa M, Ogami M, Kayo S, Yoshimi N, Hai E, Naruko T, Ohishi M, Higuchi K, et al: Mast cell chymase expression in Helicobacter pylori-associated gastritis. Histopathology. 2003, 43 (6): 538-549. 10.1111/j.1365-2559.2003.01731.x.CrossRefPubMed
26.
go back to reference Johansson B, Holm M, Ewert S, Casselbrant A, Pettersson A, Fandriks L: Angiotensin II type 2 receptor-mediated duodenal mucosal alkaline secretion in the rat. Am J Physiol Gastrointest Liver Physiol. 2001, 280 (6): G1254-1260.PubMed Johansson B, Holm M, Ewert S, Casselbrant A, Pettersson A, Fandriks L: Angiotensin II type 2 receptor-mediated duodenal mucosal alkaline secretion in the rat. Am J Physiol Gastrointest Liver Physiol. 2001, 280 (6): G1254-1260.PubMed
27.
go back to reference Wong PF, Lee SS, Cheung WT: Immunohistochemical colocalization of type II angiotensin receptors with somatostatin in rat pancreas. Regul Pept. 2004, 117 (3): 195-205. 10.1016/j.regpep.2003.10.019.CrossRefPubMed Wong PF, Lee SS, Cheung WT: Immunohistochemical colocalization of type II angiotensin receptors with somatostatin in rat pancreas. Regul Pept. 2004, 117 (3): 195-205. 10.1016/j.regpep.2003.10.019.CrossRefPubMed
28.
go back to reference de Godoy MA, Rattan S: Translocation of AT1- and AT2-receptors by higher concentrations of angiotensin II in the smooth muscle cells of rat internal anal sphincter. J Pharmacol Exp Ther. 2006, 319 (3): 1088-1095. 10.1124/jpet.106.108084.CrossRefPubMed de Godoy MA, Rattan S: Translocation of AT1- and AT2-receptors by higher concentrations of angiotensin II in the smooth muscle cells of rat internal anal sphincter. J Pharmacol Exp Ther. 2006, 319 (3): 1088-1095. 10.1124/jpet.106.108084.CrossRefPubMed
29.
go back to reference Kumar R, Singh VP, Baker KM: The intracellular renin-angiotensin system: a new paradigm. Trends Endocrinol Metab. 2007, 18 (5): 208-214. 10.1016/j.tem.2007.05.001.CrossRefPubMed Kumar R, Singh VP, Baker KM: The intracellular renin-angiotensin system: a new paradigm. Trends Endocrinol Metab. 2007, 18 (5): 208-214. 10.1016/j.tem.2007.05.001.CrossRefPubMed
30.
go back to reference Rasini E, Cosentino M, Marino F, Legnaro M, Ferrari M, Guasti L, Venco A, Lecchini S: Angiotensin II type 1 receptor expression on human leukocyte subsets: a flow cytometric and RT-PCR study. Regul Pept. 2006, 134 (2-3): 69-74. 10.1016/j.regpep.2006.01.007.CrossRefPubMed Rasini E, Cosentino M, Marino F, Legnaro M, Ferrari M, Guasti L, Venco A, Lecchini S: Angiotensin II type 1 receptor expression on human leukocyte subsets: a flow cytometric and RT-PCR study. Regul Pept. 2006, 134 (2-3): 69-74. 10.1016/j.regpep.2006.01.007.CrossRefPubMed
31.
go back to reference Elfvin A, Edebo A, Bolin I, Fandriks L: Quantitative measurement of nitric oxide and hydrogen peroxide in Helicobacter pylori-infected Mongolian gerbils in vivo. Scand J Gastroenterol. 2007, 42 (10): 1175-1181. 10.1080/00365520701288306.CrossRefPubMed Elfvin A, Edebo A, Bolin I, Fandriks L: Quantitative measurement of nitric oxide and hydrogen peroxide in Helicobacter pylori-infected Mongolian gerbils in vivo. Scand J Gastroenterol. 2007, 42 (10): 1175-1181. 10.1080/00365520701288306.CrossRefPubMed
32.
go back to reference Okuda T, Yoshida N, Takagi T, Handa O, Kokura S, Ichikawa H, Naito Y, Yoshikawa T: CV-11974, angiotensin II type I receptor antagonist, reduces the severity of indomethacin-induced rat enteritis. Digestive diseases and sciences. 2008, 53 (3): 657-663. 10.1007/s10620-007-9931-0.CrossRefPubMed Okuda T, Yoshida N, Takagi T, Handa O, Kokura S, Ichikawa H, Naito Y, Yoshikawa T: CV-11974, angiotensin II type I receptor antagonist, reduces the severity of indomethacin-induced rat enteritis. Digestive diseases and sciences. 2008, 53 (3): 657-663. 10.1007/s10620-007-9931-0.CrossRefPubMed
Metadata
Title
Angiotensin II receptor expression and relation to Helicobacter pylori-infection in the stomach of the Mongolian gerbil
Authors
Peter Hallersund
Herbert F Helander
Anna Casselbrant
Anders Edebo
Lars Fändriks
Anders Elfvin
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2010
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-10-3

Other articles of this Issue 1/2010

BMC Gastroenterology 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.